Free Trial

The Pennant Group (NASDAQ:PNTG) Trading Down 8% - What's Next?

The Pennant Group logo with Medical background

The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report) traded down 8% on Thursday . The company traded as low as $28.80 and last traded at $30.48. 98,922 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 196,096 shares. The stock had previously closed at $33.12.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Royal Bank of Canada lifted their target price on shares of The Pennant Group from $26.00 to $38.00 and gave the company an "outperform" rating in a research report on Wednesday, October 23rd. Truist Financial increased their price objective on The Pennant Group from $34.00 to $38.00 and gave the company a "hold" rating in a research note on Monday, October 7th. Stephens reaffirmed an "overweight" rating and set a $40.00 target price on shares of The Pennant Group in a research note on Wednesday, October 9th. Finally, Oppenheimer increased their target price on shares of The Pennant Group from $28.00 to $34.00 and gave the company an "outperform" rating in a research report on Thursday, August 8th.

Check Out Our Latest Stock Report on The Pennant Group

The Pennant Group Stock Down 6.1 %

The business's 50 day simple moving average is $33.82 and its 200 day simple moving average is $28.34. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.12 and a quick ratio of 1.12. The company has a market capitalization of $942.64 million, a PE ratio of 48.29, a P/E/G ratio of 3.32 and a beta of 2.02.

The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The business had revenue of $168.75 million during the quarter, compared to analysts' expectations of $156.71 million. The Pennant Group had a net margin of 3.16% and a return on equity of 13.74%. As a group, analysts anticipate that The Pennant Group, Inc. will post 0.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On The Pennant Group

Institutional investors have recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its position in The Pennant Group by 101.4% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,908 shares of the company's stock valued at $450,000 after acquiring an additional 11,536 shares in the last quarter. ClariVest Asset Management LLC lifted its position in shares of The Pennant Group by 14.9% during the 1st quarter. ClariVest Asset Management LLC now owns 87,850 shares of the company's stock worth $1,724,000 after purchasing an additional 11,359 shares during the last quarter. Sei Investments Co. lifted its position in shares of The Pennant Group by 679.7% during the 1st quarter. Sei Investments Co. now owns 136,026 shares of the company's stock worth $2,670,000 after purchasing an additional 118,581 shares during the last quarter. State Board of Administration of Florida Retirement System acquired a new position in shares of The Pennant Group during the first quarter worth $279,000. Finally, Vanguard Group Inc. increased its holdings in The Pennant Group by 4.3% in the first quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company's stock valued at $36,505,000 after buying an additional 77,052 shares during the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines